| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |